FDA applicant

Medibeacon, Inc.

St. Louis1 decision2025–20250 recalls

FDA records 1 decision for Medibeacon, Inc. (St. Louis) in 2025: 1 original PMA approval. All are in product code SDK (Transdermal Test For Assessment Of Glomerular…). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, gastroenterology and urology panel, where it files most

How often FDA has decided Medibeacon, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2025high 1 (2025)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2025.

FIG. 1 — Medibeacon, Inc. by year, 2025–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Medibeacon, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Medibeacon, Inc.

Which product codes does it file in?

What has FDA decided for it lately?